Literature DB >> 29656799

Long-term outcomes of laparoscopic versus open D3 dissection for stage II/III colon cancer: Results of propensity score analyses.

Dai Shida1, Hiroki Ochiai2, Shunsuke Tsukamoto2, Yukihide Kanemitsu2.   

Abstract

BACKGROUND: Non-inferiority of the laparoscopic approach for stage II/III colon cancer has not been clearly established. This study aimed to evaluate the long-term outcomes of laparoscopic versus open D3 surgery.
METHODS: Subjects were 1230 consecutive patients with stage II/III colon cancer, who were referred to the National Cancer Center Hospital from 2004 to 2013. Open surgery was performed in 821 (67%) patients, and laparoscopic surgery was performed in 409 (33%). Propensity score analyses with overall survival as the primary endpoint were performed in three different propensity score methods.
RESULTS: Regression adjustment using the propensity score as a linear predictor in the model showed similar overall survival between laparoscopic and open surgeries [hazard ratio (HR), 0.98 (95% CI [0.64-1.46]; p = 0.916)]. Stratification analysis of the entire cohort revealed that, among five strata, only the highest stratum (clinical T2/T3, clinical N0/N1, tumor size <6 cm, and body mass index (BMI) < 28) had an HR of <1 (0.37). In the other four strata, open surgery was favored as reflected by HRs of >1 (1.13-1.26). The propensity score-matched cohort (365 matched pairs), from which patients with advanced disease and high BMI were excluded, yielded an HR of 0.93 (95% CI [0.57-1.52]; p = 0.772).
CONCLUSIONS: Laparoscopic surgery appeared to be a safe and reasonable option for patients with stage II/III colon cancer in general. Patients with high BMI, clinical N2 and T4 disease, and tumor size ≥6 cm might require prudent selection of surgical approach.
Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Japanese D3 dissection; Laparoscopic surgery; Propensity score; Stage II/III colon cancer

Mesh:

Year:  2018        PMID: 29656799     DOI: 10.1016/j.ejso.2018.03.022

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  4 in total

1.  Clinical efficacy and quality of life after transrectal natural orifice specimen extraction for the treatment of middle and upper rectal cancer.

Authors:  Zhe Zhu; Kai-Jing Wang; Guy R Orangio; Jun-Yi Han; Bing Lu; Zhu-Qing Zhou; Wei Gao; Chuan-Gang Fu
Journal:  J Gastrointest Oncol       Date:  2020-04

2.  Laparoscopic surgery facilitates administration of adjuvant chemotherapy in locally advanced colon cancer: propensity score analyses.

Authors:  Karin Atgm Wasmann; Charlotte El Klaver; Jarmila Dw van der Bilt; Susan van Dieren; Iris D Nagtegaal; Cornelis Ja Punt; Bert van Ramshorst; Albert M Wolthuis; Johannes Hw de Wilt; André D'Hoore; Hjalmar C van Santvoort; Pieter J Tanis
Journal:  Cancer Manag Res       Date:  2019-07-29       Impact factor: 3.989

3.  Laparoscopic gastrectomy plus D2 lymphadenectomy is as effective as open surgery in terms of long-term survival: a single-institution study on gastric cancer.

Authors:  Yawei Wang; Yan Wang; Wang Wu; Xiaofang Lu; Tailai An; Jiling Jiang
Journal:  World J Surg Oncol       Date:  2021-04-07       Impact factor: 2.754

4.  Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.

Authors:  Yuya Nakamura; Dai Shida; Taro Tanabe; Yasuyuki Takamizawa; Jun Imaizumi; Yuka Ahiko; Ryohei Sakamoto; Konosuke Moritani; Shunsuke Tsukamoto; Yukihide Kanemitsu
Journal:  Cancer Med       Date:  2019-12-04       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.